Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Dysplasia of Vulva”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Ended earlyNCT03334240
What this trial is testing

ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients

Who this might be right for
HPV-Induced Genital Lesions
Maruho Co., Ltd. 28
Testing effectiveness (Phase 2)Study completedNCT03180684
What this trial is testing

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Who this might be right for
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)Vulvar DysplasiaVulvar Intraepithelial Neoplasia (VIN)+4 more
Inovio Pharmaceuticals 33
Post-approval studies (Phase 4)Not Yet RecruitingNCT06052696
What this trial is testing

Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL

Who this might be right for
Vulvar HSILHPV
Erasmus Medical Center 500
Early research (Phase 1)Study completedNCT03676101
What this trial is testing

Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancersVulvar CancerVaginal Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 90
Testing effectiveness (Phase 2)Ended earlyNCT03937791
What this trial is testing

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Who this might be right for
Squamous Lntraepithelial Lesions of VulvaNeoplasms, Squamous CellVulvar HSIL
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Looking for participantsNCT06075264
What this trial is testing

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

Who this might be right for
Vulvar DiseasesHPV InfectionVulvar HSIL+10 more
Frantz Viral Therapeutics, LLC 27
Early research (Phase 1)Study completedNCT05717621
What this trial is testing

Clinical Trial With Local Decitabine Treatment of HPV-Induced VIN Grade 2/3 (DelVIN)

Who this might be right for
Vulvar Intraepithelial Neoplasia Grade 2Vulvar Intraepithelial Neoplasia Grade 3
ViMREX GmbH 29
Not applicableWithdrawnNCT01313104
What this trial is testing

Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 1Cervical Intraepithelial Neoplasia Grade 2Cervical Intraepithelial Neoplasia Grade 3+22 more
Northwestern University
Post-approval studies (Phase 4)Study completedNCT03568604
What this trial is testing

Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia

Who this might be right for
Dyspareunia
San Diego Sexual Medicine 18